Abstract
During the last decade skin biopsy has been confirmed as a tool to provide diagnostic information on some peripheral neuropathies. Most studies were focused on intraepithelial nerve fibers and few studies have investigated large myelinated fibers or whether corpuscles in human skin change quantitatively or qualitatively in pathologies of the peripheral or central nervous system. The main objective of this article is to provide a comprehensive review of Meissner’s corpuscles including their distribution, density and age changes, development, molecular composition, cellular anatomy and physiology. We also describe their involvement in several pathologies and suggest including this dermal structure in the routine study of skin biopsies, looking for changes to be used as potential markers for several disorders. Finally the article draws the main aspects of how to study Meissner’s corpuscles in skin biopsies and gives a view on future perspectives for implementing their use in clinical practice.
Keywords: Meissner’s corpuscles, skin biopsy, neuropathy, guidelines, intraepithelial, myelinated fibers, cellular anatomy, phosphorylated neurofilaments, immunoreactivity, Schwann cells
CNS & Neurological Disorders - Drug Targets
Title:Clinical Implication of Meissner’s Corpuscles
Volume: 11 Issue: 7
Author(s): Jose A. Vega, Alfonso Lopez-Muniz, Marta G. Calavia, Olivia Garcia-Suarez, Juan Cobo, Jesus Otero, Oscar Arias-Carrion, Pablo Perez-Pinera and Manuel Menendez-Gonzalez
Affiliation:
Keywords: Meissner’s corpuscles, skin biopsy, neuropathy, guidelines, intraepithelial, myelinated fibers, cellular anatomy, phosphorylated neurofilaments, immunoreactivity, Schwann cells
Abstract: During the last decade skin biopsy has been confirmed as a tool to provide diagnostic information on some peripheral neuropathies. Most studies were focused on intraepithelial nerve fibers and few studies have investigated large myelinated fibers or whether corpuscles in human skin change quantitatively or qualitatively in pathologies of the peripheral or central nervous system. The main objective of this article is to provide a comprehensive review of Meissner’s corpuscles including their distribution, density and age changes, development, molecular composition, cellular anatomy and physiology. We also describe their involvement in several pathologies and suggest including this dermal structure in the routine study of skin biopsies, looking for changes to be used as potential markers for several disorders. Finally the article draws the main aspects of how to study Meissner’s corpuscles in skin biopsies and gives a view on future perspectives for implementing their use in clinical practice.
Export Options
About this article
Cite this article as:
A. Vega Jose, Lopez-Muniz Alfonso, G. Calavia Marta, Garcia-Suarez Olivia, Cobo Juan, Otero Jesus, Arias-Carrion Oscar, Perez-Pinera Pablo and Menendez-Gonzalez Manuel, Clinical Implication of Meissner’s Corpuscles, CNS & Neurological Disorders - Drug Targets 2012; 11 (7) . https://dx.doi.org/10.2174/1871527311201070856
DOI https://dx.doi.org/10.2174/1871527311201070856 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anti-Inflammatory Activity of Tetracyclines: Applications to Human Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Recent Patents on Drugs Addressing Neurodegenerative Diseases
Recent Patents on Biomarkers Exercise Training-Associated Changes in Arterial Stiffness and Endothelium-Derived Vasoactive Factors
Current Hypertension Reviews 9th International Meeting on Metabotropic Gglutamate Receptors (Taormina, Sicily, October 1-6, 2017).
Current Neuropharmacology Angiotensin Peptides as AT2 Receptor Agonists
Current Protein & Peptide Science Neurovascular Mechanisms of Hypertension in Pregnancy
Current Neurovascular Research Experimental and Clinical Application of Plasmid DNA in the Field of Central Nervous Diseases
Current Gene Therapy Beta-Adrenoreceptor Modulation of Metabolic, Endocrine and Immunologic Function During Critical Illness
Endocrine, Metabolic & Immune Disorders - Drug Targets Immunomodulatory Effects of <i>Allium sativum</i> L. and its Constituents against Viral Infections and Metabolic Diseases
Current Topics in Medicinal Chemistry Regulatory Strategies for Cell Death in Neurological Diseases
CNS & Neurological Disorders - Drug Targets Angiopoietin-1 and C16 Peptide Attenuate Vascular and Inflammatory Responses in Experimental Allergic Encephalomyelitis
CNS & Neurological Disorders - Drug Targets Uncovering New Pharmacological Targets to Treat Neuropathic Pain by Understanding How the Organism Reacts to Nerve Injury
Current Pharmaceutical Design Trafficking and Signaling of G Protein-Coupled Receptors in the Nervous System: Implications for Disease and Therapy
CNS & Neurological Disorders - Drug Targets Is There a Role for Cytokine Based Therapies in Fibromyalgia
Current Pharmaceutical Design The Radiological Evaluation of Posterior Superior Alveolar Artery by Using CBCT
Current Medical Imaging Compartmentalized Platforms for Neuro-Pharmacological Research
Current Neuropharmacology Potential Therapeutic Effects of Oleuropein Aglycone in Alzheimer's Disease
Current Pharmaceutical Biotechnology Iron Chelating Strategies in Systemic Metal Overload, Neurodegeneration and Cancer
Current Medicinal Chemistry The Vanilloid Agonist Resiniferatoxin for Interventional-Based Pain Control
Current Topics in Medicinal Chemistry Control of Neuropathic Pain by Immune Cells and Opioids
CNS & Neurological Disorders - Drug Targets